Latest in treatment for Hodgkin Lymphoma, Park comments at annual ASH meeting
by
Mary Ruth Helms
—
last modified
Feb 14, 2012 02:54 PM
As part of Patient Power® coverage of the annual meeting of the American Society of Hematology (ASH), UNC Lineberger member Steven Park, MD, talks about the latest in treatment for Hodgkin Lymphoma.
Dr. Park is an assistant professor in the Division of Hematology and Oncology.
.Patient Power® is a service for cancer patients and their families that provides information through programs, webcasts, blog posts, and more.
The ASH annual meeting was held December 10 - 13, 2011 in San Diego, California. ASH is the world’s largest professional society focused on the causes and treatments of blood disorders. Its goal is to further the understanding, diagnosis, treatment, and prevention of these disorders.
